In order to evaluate the extent and
nature of any kind of cancer, including mesothelioma cancer, oncologists use a rubric or
“staging” system. This is only one of the benchmarks used to classify
malignancies. Additional criteria include the location of the tumor and
identification of mesothelioma
cell types.
Staging assists mesothelioma
doctors in
determining how far the asbestos
cancer has
advanced and what mesothelioma
treatment would
be appropriate for the patient’s malignancy.
Although there are three distinct
staging systems currently in use, all three are based on four primary stages
relative to the assessment of the tumor:
- The tumor in stage 1 mesothelioma is confined to one organ or region and is relatively small.
- The tumor in stage 2 mesothelioma has grown in size, and has spread to one other tissue.
- The tumor in stage 3 mesothelioma has spread to adjacent areas.
- The tumor in stage 4 mesothelioma has spread to distant areas of
the body, or “metastasized.”
In Stage 4, the cancer has spread
throughout the body and the anticipated mesothelioma life expectancy is not long.
0 comentários: